Your browser doesn't support javascript.
loading
Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells.
Garreta, Elena; Moya-Rull, Daniel; Stanifer, Megan L; Monteil, Vanessa; Prado, Patricia; Marco, Andrés; Tarantino, Carolina; Gallo, Maria; Jonsson, Gustav; Hagelkruys, Astrid; Mirazimi, Ali; Boulant, Steeve; Penninger, Josef M; Montserrat, Nuria.
Afiliación
  • Garreta E; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Moya-Rull D; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Stanifer ML; Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, 69120 Heidelberg, Germany; Research Group "Cellular Polarity and Viral Infection", German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department of Molecular Genetics and Microbiology, College of Med
  • Monteil V; Karolinska Institute and Karolinska University Hospital, Unit of Clinical Microbiology, 17182 Stockholm, Sweden.
  • Prado P; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Marco A; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Tarantino C; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Gallo M; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.
  • Jonsson G; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr-Gasse 3, 1030 Vienna, Austria.
  • Hagelkruys A; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr-Gasse 3, 1030 Vienna, Austria.
  • Mirazimi A; Karolinska Institute and Karolinska University Hospital, Unit of Clinical Microbiology, 17182 Stockholm, Sweden; National Veterinary Institute, 751 89 Uppsala, Sweden. Electronic address: ali.mirazimi@ki.se.
  • Boulant S; Research Group "Cellular Polarity and Viral Infection", German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL, USA; Department of Infectious Diseases, Virology, Heidelberg Univer
  • Penninger JM; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohr-Gasse 3, 1030 Vienna, Austria; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: josef.penninger@ubc.ca.
  • Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain; Centro de Investigación Biomédica en Red en Bioing
STAR Protoc ; 3(4): 101872, 2022 12 16.
Article en En | MEDLINE | ID: mdl-36595951

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Pluripotentes / COVID-19 Límite: Humans Idioma: En Revista: STAR Protoc Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Madre Pluripotentes / COVID-19 Límite: Humans Idioma: En Revista: STAR Protoc Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos